New York, Dec. 27, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Rabies Diagnostics Industry" - https://www.reportlinker.com/p06032717/?utm_source=GNW
8% over the analysis period 2020-2027. Fluorescent Antibody Tests (FAT), one of the segments analyzed in the report, is projected to record a 5.6% CAGR and reach US$751.9 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Immunohistochemical Tests segment is readjusted to a revised 5.9% CAGR for the next 7-year period.
The U.S. Market is Estimated at $418.9 Million, While China is Forecast to Grow at 8.6% CAGR
The Rabies Diagnostics market in the U.S. is estimated at US$418.9 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$459.8 Million by the year 2027 trailing a CAGR of 8.6% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.9% and 4.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$301 Million by the year 2027.
Amplification Methods Segment to Record 6.4% CAGR
In the global Amplification Methods segment, USA, Canada, Japan, China and Europe will drive the 6.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$266.1 Million in the year 2020 will reach a projected size of US$402.6 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Latin America will expand at a 6.8% CAGR through the analysis period.
Select Competitors (Total 34 Featured) -
Abbexa Ltd.
Aviva Systems Biology Corporation
BioNote, Inc.
Bio-Rad Laboratories, Inc.
Creative Diagnostics
Demeditec Diagnostics GmbH
Express Biotech International Inc.
Merck KGaA
MyBioSource.com
Norgen Biotek Corp.
Read the full report: https://www.reportlinker.com/p06032717/?utm_source=GNW
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
Rabies Diagnostics - Global Key Competitors Percentage Market
Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Rabies Diagnostics by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 2: World Historic Review for Rabies Diagnostics by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 3: World 15-Year Perspective for Rabies Diagnostics by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets for Years 2012, 2021 & 2027
Table 4: World Recent Past, Current & Future Analysis for
Fluorescent Antibody Tests (FAT) by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 5: World Historic Review for Fluorescent Antibody Tests
(FAT) by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 6: World 15-Year Perspective for Fluorescent Antibody
Tests (FAT) by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2021 & 2027
Table 7: World Recent Past, Current & Future Analysis for
Immunohistochemical Tests by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR
Table 8: World Historic Review for Immunohistochemical Tests by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 9: World 15-Year Perspective for Immunohistochemical
Tests by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2021 &
2027
Table 10: World Recent Past, Current & Future Analysis for
Amplification Methods by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR
Table 11: World Historic Review for Amplification Methods by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 12: World 15-Year Perspective for Amplification Methods
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 13: World Recent Past, Current & Future Analysis for
Histologic Examinations by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR
Table 14: World Historic Review for Histologic Examinations by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 15: World 15-Year Perspective for Histologic Examinations
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 16: World Recent Past, Current & Future Analysis for
Serology Tests by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 17: World Historic Review for Serology Tests by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 18: World 15-Year Perspective for Serology Tests by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 19: World Recent Past, Current & Future Analysis for
ELISA / Immunohistochemistry by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Table 20: World Historic Review for ELISA /
Immunohistochemistry by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 21: World 15-Year Perspective for ELISA /
Immunohistochemistry by Geographic Region - Percentage
Breakdown of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa for Years
2012, 2021 & 2027
Table 22: World Recent Past, Current & Future Analysis for
Chromatography by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 23: World Historic Review for Chromatography by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 24: World 15-Year Perspective for Chromatography by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 25: World Recent Past, Current & Future Analysis for PCR
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 26: World Historic Review for PCR by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 27: World 15-Year Perspective for PCR by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027
Table 28: World Recent Past, Current & Future Analysis for
Other Technologies by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR
Table 29: World Historic Review for Other Technologies by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 30: World 15-Year Perspective for Other Technologies by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027
Table 31: World Rabies Diagnostics Market Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2027
III. MARKET ANALYSIS
UNITED STATES
Rabies Diagnostics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United States for 2022 (E)
Table 32: USA Recent Past, Current & Future Analysis for Rabies
Diagnostics by Method - Fluorescent Antibody Tests (FAT),
Immunohistochemical Tests, Amplification Methods, Histologic
Examinations and Serology Tests - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 33: USA Historic Review for Rabies Diagnostics by Method -
Fluorescent Antibody Tests (FAT), Immunohistochemical Tests,
Amplification Methods, Histologic Examinations and Serology
Tests Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 34: USA 15-Year Perspective for Rabies Diagnostics by
Method - Percentage Breakdown of Value Sales for Fluorescent
Antibody Tests (FAT), Immunohistochemical Tests, Amplification
Methods, Histologic Examinations and Serology Tests for the
Years 2012, 2021 & 2027
Table 35: USA Recent Past, Current & Future Analysis for Rabies
Diagnostics by Technology - ELISA / Immunohistochemistry,
Chromatography, PCR and Other Technologies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 36: USA Historic Review for Rabies Diagnostics by
Technology - ELISA / Immunohistochemistry, Chromatography, PCR
and Other Technologies Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 37: USA 15-Year Perspective for Rabies Diagnostics by
Technology - Percentage Breakdown of Value Sales for ELISA /
Immunohistochemistry, Chromatography, PCR and Other
Technologies for the Years 2012, 2021 & 2027
CANADA
Table 38: Canada Recent Past, Current & Future Analysis for
Rabies Diagnostics by Method - Fluorescent Antibody Tests
(FAT), Immunohistochemical Tests, Amplification Methods,
Histologic Examinations and Serology Tests - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 39: Canada Historic Review for Rabies Diagnostics by
Method - Fluorescent Antibody Tests (FAT), Immunohistochemical
Tests, Amplification Methods, Histologic Examinations and
Serology Tests Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 40: Canada 15-Year Perspective for Rabies Diagnostics by
Method - Percentage Breakdown of Value Sales for Fluorescent
Antibody Tests (FAT), Immunohistochemical Tests, Amplification
Methods, Histologic Examinations and Serology Tests for the
Years 2012, 2021 & 2027
Table 41: Canada Recent Past, Current & Future Analysis for
Rabies Diagnostics by Technology - ELISA /
Immunohistochemistry, Chromatography, PCR and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 42: Canada Historic Review for Rabies Diagnostics by
Technology - ELISA / Immunohistochemistry, Chromatography, PCR
and Other Technologies Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 43: Canada 15-Year Perspective for Rabies Diagnostics by
Technology - Percentage Breakdown of Value Sales for ELISA /
Immunohistochemistry, Chromatography, PCR and Other
Technologies for the Years 2012, 2021 & 2027
JAPAN
Rabies Diagnostics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Japan for 2022 (E)
Table 44: Japan Recent Past, Current & Future Analysis for
Rabies Diagnostics by Method - Fluorescent Antibody Tests
(FAT), Immunohistochemical Tests, Amplification Methods,
Histologic Examinations and Serology Tests - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 45: Japan Historic Review for Rabies Diagnostics by
Method - Fluorescent Antibody Tests (FAT), Immunohistochemical
Tests, Amplification Methods, Histologic Examinations and
Serology Tests Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 46: Japan 15-Year Perspective for Rabies Diagnostics by
Method - Percentage Breakdown of Value Sales for Fluorescent
Antibody Tests (FAT), Immunohistochemical Tests, Amplification
Methods, Histologic Examinations and Serology Tests for the
Years 2012, 2021 & 2027
Table 47: Japan Recent Past, Current & Future Analysis for
Rabies Diagnostics by Technology - ELISA /
Immunohistochemistry, Chromatography, PCR and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 48: Japan Historic Review for Rabies Diagnostics by
Technology - ELISA / Immunohistochemistry, Chromatography, PCR
and Other Technologies Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 49: Japan 15-Year Perspective for Rabies Diagnostics by
Technology - Percentage Breakdown of Value Sales for ELISA /
Immunohistochemistry, Chromatography, PCR and Other
Technologies for the Years 2012, 2021 & 2027
CHINA
Rabies Diagnostics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in China for 2022 (E)
Table 50: China Recent Past, Current & Future Analysis for
Rabies Diagnostics by Method - Fluorescent Antibody Tests
(FAT), Immunohistochemical Tests, Amplification Methods,
Histologic Examinations and Serology Tests - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 51: China Historic Review for Rabies Diagnostics by
Method - Fluorescent Antibody Tests (FAT), Immunohistochemical
Tests, Amplification Methods, Histologic Examinations and
Serology Tests Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 52: China 15-Year Perspective for Rabies Diagnostics by
Method - Percentage Breakdown of Value Sales for Fluorescent
Antibody Tests (FAT), Immunohistochemical Tests, Amplification
Methods, Histologic Examinations and Serology Tests for the
Years 2012, 2021 & 2027
Table 53: China Recent Past, Current & Future Analysis for
Rabies Diagnostics by Technology - ELISA /
Immunohistochemistry, Chromatography, PCR and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 54: China Historic Review for Rabies Diagnostics by
Technology - ELISA / Immunohistochemistry, Chromatography, PCR
and Other Technologies Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 55: China 15-Year Perspective for Rabies Diagnostics by
Technology - Percentage Breakdown of Value Sales for ELISA /
Immunohistochemistry, Chromatography, PCR and Other
Technologies for the Years 2012, 2021 & 2027
EUROPE
Rabies Diagnostics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Europe for 2022 (E)
Table 56: Europe Recent Past, Current & Future Analysis for
Rabies Diagnostics by Geographic Region - France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR
Table 57: Europe Historic Review for Rabies Diagnostics by
Geographic Region - France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 58: Europe 15-Year Perspective for Rabies Diagnostics by
Geographic Region - Percentage Breakdown of Value Sales for
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets for Years 2012, 2021 & 2027
Table 59: Europe Recent Past, Current & Future Analysis for
Rabies Diagnostics by Method - Fluorescent Antibody Tests
(FAT), Immunohistochemical Tests, Amplification Methods,
Histologic Examinations and Serology Tests - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 60: Europe Historic Review for Rabies Diagnostics by
Method - Fluorescent Antibody Tests (FAT), Immunohistochemical
Tests, Amplification Methods, Histologic Examinations and
Serology Tests Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 61: Europe 15-Year Perspective for Rabies Diagnostics by
Method - Percentage Breakdown of Value Sales for Fluorescent
Antibody Tests (FAT), Immunohistochemical Tests, Amplification
Methods, Histologic Examinations and Serology Tests for the
Years 2012, 2021 & 2027
Table 62: Europe Recent Past, Current & Future Analysis for
Rabies Diagnostics by Technology - ELISA /
Immunohistochemistry, Chromatography, PCR and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 63: Europe Historic Review for Rabies Diagnostics by
Technology - ELISA / Immunohistochemistry, Chromatography, PCR
and Other Technologies Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 64: Europe 15-Year Perspective for Rabies Diagnostics by
Technology - Percentage Breakdown of Value Sales for ELISA /
Immunohistochemistry, Chromatography, PCR and Other
Technologies for the Years 2012, 2021 & 2027
FRANCE
Rabies Diagnostics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in France for 2022 (E)
Table 65: France Recent Past, Current & Future Analysis for
Rabies Diagnostics by Method - Fluorescent Antibody Tests
(FAT), Immunohistochemical Tests, Amplification Methods,
Histologic Examinations and Serology Tests - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 66: France Historic Review for Rabies Diagnostics by
Method - Fluorescent Antibody Tests (FAT), Immunohistochemical
Tests, Amplification Methods, Histologic Examinations and
Serology Tests Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 67: France 15-Year Perspective for Rabies Diagnostics by
Method - Percentage Breakdown of Value Sales for Fluorescent
Antibody Tests (FAT), Immunohistochemical Tests, Amplification
Methods, Histologic Examinations and Serology Tests for the
Years 2012, 2021 & 2027
Table 68: France Recent Past, Current & Future Analysis for
Rabies Diagnostics by Technology - ELISA /
Immunohistochemistry, Chromatography, PCR and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 69: France Historic Review for Rabies Diagnostics by
Technology - ELISA / Immunohistochemistry, Chromatography, PCR
and Other Technologies Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 70: France 15-Year Perspective for Rabies Diagnostics by
Technology - Percentage Breakdown of Value Sales for ELISA /
Immunohistochemistry, Chromatography, PCR and Other
Technologies for the Years 2012, 2021 & 2027
GERMANY
Rabies Diagnostics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Germany for 2022 (E)
Table 71: Germany Recent Past, Current & Future Analysis for
Rabies Diagnostics by Method - Fluorescent Antibody Tests
(FAT), Immunohistochemical Tests, Amplification Methods,
Histologic Examinations and Serology Tests - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 72: Germany Historic Review for Rabies Diagnostics by
Method - Fluorescent Antibody Tests (FAT), Immunohistochemical
Tests, Amplification Methods, Histologic Examinations and
Serology Tests Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 73: Germany 15-Year Perspective for Rabies Diagnostics by
Method - Percentage Breakdown of Value Sales for Fluorescent
Antibody Tests (FAT), Immunohistochemical Tests, Amplification
Methods, Histologic Examinations and Serology Tests for the
Years 2012, 2021 & 2027
Table 74: Germany Recent Past, Current & Future Analysis for
Rabies Diagnostics by Technology - ELISA /
Immunohistochemistry, Chromatography, PCR and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 75: Germany Historic Review for Rabies Diagnostics by
Technology - ELISA / Immunohistochemistry, Chromatography, PCR
and Other Technologies Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 76: Germany 15-Year Perspective for Rabies Diagnostics by
Technology - Percentage Breakdown of Value Sales for ELISA /
Immunohistochemistry, Chromatography, PCR and Other
Technologies for the Years 2012, 2021 & 2027
ITALY
Table 77: Italy Recent Past, Current & Future Analysis for
Rabies Diagnostics by Method - Fluorescent Antibody Tests
(FAT), Immunohistochemical Tests, Amplification Methods,
Histologic Examinations and Serology Tests - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 78: Italy Historic Review for Rabies Diagnostics by
Method - Fluorescent Antibody Tests (FAT), Immunohistochemical
Tests, Amplification Methods, Histologic Examinations and
Serology Tests Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 79: Italy 15-Year Perspective for Rabies Diagnostics by
Method - Percentage Breakdown of Value Sales for Fluorescent
Antibody Tests (FAT), Immunohistochemical Tests, Amplification
Methods, Histologic Examinations and Serology Tests for the
Years 2012, 2021 & 2027
Table 80: Italy Recent Past, Current & Future Analysis for
Rabies Diagnostics by Technology - ELISA /
Immunohistochemistry, Chromatography, PCR and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 81: Italy Historic Review for Rabies Diagnostics by
Technology - ELISA / Immunohistochemistry, Chromatography, PCR
and Other Technologies Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 82: Italy 15-Year Perspective for Rabies Diagnostics by
Technology - Percentage Breakdown of Value Sales for ELISA /
Immunohistochemistry, Chromatography, PCR and Other
Technologies for the Years 2012, 2021 & 2027
UNITED KINGDOM
Rabies Diagnostics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in the United Kingdom for 2022 (E)
Table 83: UK Recent Past, Current & Future Analysis for Rabies
Diagnostics by Method - Fluorescent Antibody Tests (FAT),
Immunohistochemical Tests, Amplification Methods, Histologic
Examinations and Serology Tests - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR
Table 84: UK Historic Review for Rabies Diagnostics by Method -
Fluorescent Antibody Tests (FAT), Immunohistochemical Tests,
Amplification Methods, Histologic Examinations and Serology
Tests Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR
Table 85: UK 15-Year Perspective for Rabies Diagnostics by
Method - Percentage Breakdown of Value Sales for Fluorescent
Antibody Tests (FAT), Immunohistochemical Tests, Amplification
Methods, Histologic Examinations and Serology Tests for the
Years 2012, 2021 & 2027
Table 86: UK Recent Past, Current & Future Analysis for Rabies
Diagnostics by Technology - ELISA / Immunohistochemistry,
Chromatography, PCR and Other Technologies - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 87: UK Historic Review for Rabies Diagnostics by
Technology - ELISA / Immunohistochemistry, Chromatography, PCR
and Other Technologies Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 88: UK 15-Year Perspective for Rabies Diagnostics by
Technology - Percentage Breakdown of Value Sales for ELISA /
Immunohistochemistry, Chromatography, PCR and Other
Technologies for the Years 2012, 2021 & 2027
SPAIN
Table 89: Spain Recent Past, Current & Future Analysis for
Rabies Diagnostics by Method - Fluorescent Antibody Tests
(FAT), Immunohistochemical Tests, Amplification Methods,
Histologic Examinations and Serology Tests - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 90: Spain Historic Review for Rabies Diagnostics by
Method - Fluorescent Antibody Tests (FAT), Immunohistochemical
Tests, Amplification Methods, Histologic Examinations and
Serology Tests Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 91: Spain 15-Year Perspective for Rabies Diagnostics by
Method - Percentage Breakdown of Value Sales for Fluorescent
Antibody Tests (FAT), Immunohistochemical Tests, Amplification
Methods, Histologic Examinations and Serology Tests for the
Years 2012, 2021 & 2027
Table 92: Spain Recent Past, Current & Future Analysis for
Rabies Diagnostics by Technology - ELISA /
Immunohistochemistry, Chromatography, PCR and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 93: Spain Historic Review for Rabies Diagnostics by
Technology - ELISA / Immunohistochemistry, Chromatography, PCR
and Other Technologies Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 94: Spain 15-Year Perspective for Rabies Diagnostics by
Technology - Percentage Breakdown of Value Sales for ELISA /
Immunohistochemistry, Chromatography, PCR and Other
Technologies for the Years 2012, 2021 & 2027
RUSSIA
Table 95: Russia Recent Past, Current & Future Analysis for
Rabies Diagnostics by Method - Fluorescent Antibody Tests
(FAT), Immunohistochemical Tests, Amplification Methods,
Histologic Examinations and Serology Tests - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 96: Russia Historic Review for Rabies Diagnostics by
Method - Fluorescent Antibody Tests (FAT), Immunohistochemical
Tests, Amplification Methods, Histologic Examinations and
Serology Tests Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 97: Russia 15-Year Perspective for Rabies Diagnostics by
Method - Percentage Breakdown of Value Sales for Fluorescent
Antibody Tests (FAT), Immunohistochemical Tests, Amplification
Methods, Histologic Examinations and Serology Tests for the
Years 2012, 2021 & 2027
Table 98: Russia Recent Past, Current & Future Analysis for
Rabies Diagnostics by Technology - ELISA /
Immunohistochemistry, Chromatography, PCR and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 99: Russia Historic Review for Rabies Diagnostics by
Technology - ELISA / Immunohistochemistry, Chromatography, PCR
and Other Technologies Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 100: Russia 15-Year Perspective for Rabies Diagnostics by
Technology - Percentage Breakdown of Value Sales for ELISA /
Immunohistochemistry, Chromatography, PCR and Other
Technologies for the Years 2012, 2021 & 2027
REST OF EUROPE
Table 101: Rest of Europe Recent Past, Current & Future
Analysis for Rabies Diagnostics by Method - Fluorescent
Antibody Tests (FAT), Immunohistochemical Tests, Amplification
Methods, Histologic Examinations and Serology Tests -
Independent Analysis of Annual Sales in US$ Thousand for the
Years 2020 through 2027 and % CAGR
Table 102: Rest of Europe Historic Review for Rabies
Diagnostics by Method - Fluorescent Antibody Tests (FAT),
Immunohistochemical Tests, Amplification Methods, Histologic
Examinations and Serology Tests Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 103: Rest of Europe 15-Year Perspective for Rabies
Diagnostics by Method - Percentage Breakdown of Value Sales for
Fluorescent Antibody Tests (FAT), Immunohistochemical Tests,
Amplification Methods, Histologic Examinations and Serology
Tests for the Years 2012, 2021 & 2027
Table 104: Rest of Europe Recent Past, Current & Future
Analysis for Rabies Diagnostics by Technology - ELISA /
Immunohistochemistry, Chromatography, PCR and Other
Technologies - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR
Table 105: Rest of Europe Historic Review for Rabies
Diagnostics by Technology - ELISA / Immunohistochemistry,
Chromatography, PCR and Other Technologies Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR
Table 106: Rest of Europe 15-Year Perspective for Rabies
Diagnostics by Technology - Percentage Breakdown of Value Sales
for ELISA / Immunohistochemistry, Chromatography, PCR and Other
Technologies for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Rabies Diagnostics Market Presence - Strong/Active/Niche/
Trivial - Key Competitors in Asia-Pacific for 2022 (E)
Table 107: Asia-Pacific Recent Past, Current & Future Analysis
for Rabies Diagnostics by Geographic Region - Australia, India,
South Korea and Rest of Asia-Pacific Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2020 through
2027 and % CAGR
Table 108: Asia-Pacific Historic Review for Rabies Diagnostics
by Geographic Region - Australia, India, South Korea and Rest
of Asia-Pacific Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2012 through 2019 and % CAGR
Table 109: Asia-Pacific 15-Year Perspective for Rabies
Diagnostics by Geographic Region - Percentage Breakdown of
Value Sales for Australia, India, South Korea and Rest of
Asia-Pacific Markets for Years 2012, 2021 & 2027
Table 110: Asia-Pacific Recent Past, Current & Future Analysis
for Rabies Diagnostics by Method - Fluorescent Antibody Tests
(FAT), Immunohistochemical Tests, Amplification Methods,
Histologic Examinations and Serology Tests - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR
Table 111: Asia-Pacific Historic Review for Rabies Diagnostics
by Method - Fluorescent Antibody Tests (FAT),
Immunohistochemical Tests, Amplification Methods, Histologic
Examinations and Serology Tests Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR
Table 112: Asia-Pacific 15-Year Perspective for Rabies
Diagnostics by Method - Percentage Breakdown of Value Sales for
Fluorescent Antibody Tests (FAT), Immunohistochemical Tests,
Amplification Methods, Histologic Examinations and Serology
Tests for the Years 2012, 2021 & 2027
Table 113: Asia-Pacific Recent Past, Current & Future Analysis
for Rabies Diagnostics by Technology - ELISA /
Immunohistochemistry, Chromatography, PCR and Other
Technologies - Independent Analysis of Annual Sales in US$
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p06032717/?utm_source=GNW
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
__________________________
